Lineage (LINE): The Cold-Storage Turn Is Real. So Is the Leverage.

Morgan Stanley just upgraded Lineage, Inc. (NASDAQ: LINE) from Equalweight to Overweight with a $47 price target — roughly 24% above where the stock trades. Read as an endorsement, the headline overpromises. Read as a cycle call, it is the more useful thing: the note says the cold-storage industry that Lineage dominates has stopped getting worse, and is starting to turn. Whether that turn is real decides the entire investment case for this stock, so it is worth checking the numbers behind the upgrade before treating it as a buy signal.

Lineage is the world's largest cold-storage landlord, the temperature-controlled counterpart to a warehouse REIT like Prologis, with more than 500 facilities across North America, Europe, and Asia-Pacific. It went public in July 2024 at $78 a share — the largest real estate IPO on record — and used the proceeds to pay down debt. The stock has since been cut roughly in half, and the reason is spelled out in the sector's history, not in the company's story. From 2021 to 2025, U.S. refrigerated-warehouse supply grew about 15% on a square-foot basis while demand grew only about 5%. Developers built ahead of a market that never came, and vacancy sat at 20-year highs with occupancy falling.

Here is the inflection. In the second quarter of 2026, the sector's year-over-year occupancy swing turned positive for the first time in years: down 320 basis points in Q2 2024, down 330 basis points in Q2 2025, then up 50 basis points in Q2 2026. On the supply side, new deliveries are drying up — cold-storage stock grew just 1.3% year over year in Q2 2026, down from 2.7% a year earlier. When demand stops falling at the same time new space stops coming, occupancy and pricing power have room to recover. That is the whole argument for the upgrade in one sentence.

Lineage's own results line up with it. In the quarter ended in June, same-store physical occupancy rose 90 basis points to 75.8% — the first such increase since the company went public. Management raised full-year guidance for adjusted funds from operations (AFFO), the cash-based measure REITs use instead of GAAP earnings, to a range of $2.80 to $3.05 a share — and did so while swallowing a roughly $15 million hit to adjusted EBITDA from a fire at its Big Bear facility (a warehouse it acquired as part of a pending deal). In plain terms: the metric that pays for the dividend is creeping up.

Now the part the headline does not carry. In the way I read factor stacks, this is a stock with an improving report card, not yet a strong one — and the reason is that you are buying the turn through leverage. Lineage carries about $6.2 billion in net debt, a debt-to-equity ratio near 0.7, negative GAAP earnings, and an operating margin around 3.6% with very thin returns on invested capital. The 5.6% dividend yield and a share price below book value (about 0.96x) cushion the downside, and low-double-digit EV/EBITDA is reasonable for a cold-storage REIT sitting near the bottom of an occupancy cycle. But cheap here is partly a function of the cycle, not just of the company. And the market has not yet paid up for the turn: the stock sits below its 200-day average with an RSI near 30 and is down roughly 10% over the past month even after the earnings beat. Momentum has not confirmed the story yet.

Lineage is not alone in the inflection, which is part of how you know the signal is sector-wide rather than a single-company fluke. Americold, the other Tier-1 cold-storage REIT, reported the same stabilization in its own Q2 — adjusted FFO of $0.35 a share with a raised full-year guide — and simultaneously sold a $1.3 billion stake in a new joint venture to strengthen its balance sheet. The industry is turning, and, industry-wide, the balance sheets are the constraint on how smoothly.

So what does the factor stack tell you to do with LINE? This is a high-yield, early-cycle, leveraged bet on a turn — the income-plus-recovery sleeve of a barbell, not a core quality holding. The 5.6% yield is the payment you collect for waiting on the cycle to feed through, and the dividend is meaningfully covered by the raised AFFO range. The trigger that would change the story is the same one the upgrade rests on: if occupancy keeps climbing and AFFO guidance keeps rising, ~13x EV/EBITDA with a sub-book price starts to look flattering; if occupancy stalls again, or the development pipeline revives, leverage makes the downside hurt more than it helps. Consensus still labels the stock Hold, so the Morgan Stanley upgrade is a divergence, not a sector-wide rush. The cycle is pointing the right way. Treat it as a getting-better-with-evidence income trade, not as a conviction compounder — and let the occupancy and AFFO trend, not the price target, tell you when the story breaks.